LUNDQUIST INSTITUTE FOR BIOMEDICAL… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1952

Legal Domicile

Principal Officer

DAVID MEYER

Phone

3102223605

Tax Period

2022-07-01 to 2023-06-30

LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER, founded in 1952, is a mid-sized nonprofit in the Medical Research sector that reported $91.6M in total revenue in fiscal year 2022.

Mission

TO ENGAGE IN BIOMEDICAL RESEARCH, TRAIN YOUNG SCIENTISTS, AND PROVIDE COMMUNITY HEALTH SERVICES.

Program Service Accomplishments

Program 1

Expenses: $39,472,000

MEDICAL RESEARCH: MEDICAL RESEARCH, SPONSORED BY THE NATIONAL INSTITUTES OF HEALTH AND OTHER FEDERAL, STATE AND PRIVATE AGENCIES, COVERING MANY DIVERSE MEDICAL AND SCIENTIFIC AREAS OF INTEREST IN...

MEDICAL RESEARCH: MEDICAL RESEARCH, SPONSORED BY THE NATIONAL INSTITUTES OF HEALTH AND OTHER FEDERAL, STATE AND PRIVATE AGENCIES, COVERING MANY DIVERSE MEDICAL AND SCIENTIFIC AREAS OF INTEREST IN HUMAN HEALTH.

Program 2

Expenses: $15,241,000 Revenue: $4,229,415

HEALTH CARE PROGRAM: LUNDQUIST INSTITUTE CLINICAL OUTREACH INCLUDES WOMEN, INFANTS AND CHILDREN (WIC) CLINICS, PARTICIPATION IN THE SOUTH LOS ANGELES BEST BABIES COLLABORATIVE, IMMUNIZE LA KIDS...

HEALTH CARE PROGRAM: LUNDQUIST INSTITUTE CLINICAL OUTREACH INCLUDES WOMEN, INFANTS AND CHILDREN (WIC) CLINICS, PARTICIPATION IN THE SOUTH LOS ANGELES BEST BABIES COLLABORATIVE, IMMUNIZE LA KIDS COALITION, NEWBORN SCREENING PROGRAM, PERINATAL ACCESS PROGRAM, A WOMEN'S HEALTHCARE CLINIC, AND VARIOUS EDUCATIONAL PROGRAMS.

Program 3

Expenses: $9,283,000

SCIENCE & TECHNOLOGY: TRAINING OF MEDICAL STUDENTS, INTERNS, RESIDENTS, AND POST GRADUATES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $83,433,111

Program Service Revenue $4,686,360

Investment Income $1,450,057

Other Revenue $2,055,534

TOTAL REVENUE $91,625,062

Expense Breakdown

Grants Paid $515,624

Salaries & Benefits $57,498,592

Fundraising Expenses $1,384,694

Program Expenses $67,135,000

Other Expenses $41,174,846

TOTAL EXPENSES $99,189,062

Year-over-Year Comparison

	2022	2021	Change
Revenue	$91,625,062	$85,153,761	+0.1%
Expenses	$99,189,062	$91,968,761	+0.1%
Net Income	$-7,564,000	$-6,815,000	+0.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

768

Volunteers

900

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,643,914

Total Directors

$1,267,070

Key Employees

$1,009,415

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RICARDO AZZIZ	EVP/OPERATIONS/STRATEGY/SCI. AFFAIRS	40.00	Officer	$643,436	$26,546	$669,982
DAVID MEYER	PRESIDENT & CEO	40.00	Officer Director	$661,105	$710	$661,815
ASHRAF IBRAHIM	INVESTIGATOR	40.00	Highest	$440,446	$28,058	$468,504
WEI YAN	INVESTIGATOR	40.00	Highest	$333,735	$10,924	$344,659
MATTHEW BUDOFF	INVESTIGATOR	40.00	Highest	$275,790	$27,918	$303,708
JODY SPILLANE	SVP, PUBLIC AFFAIRS	40.00	Key Emp	$294,603	$846	$295,449
ROSEMARY MADNICK	VP, RESEARCH ADMINISTRATION	40.00	Key Emp	$234,217	$32,785	$267,002
KAREN MAYO	VP, SUPPORT OPERATIONS	40.00	Key Emp	$221,321	$23,799	$245,120
MICHAEL YEAMAN	INVESTIGATOR	40.00	Highest	$230,398	$0	$230,398
MS LYNDA POLGREEN	BOARD MEMBER/INVESTIGATOR	40.00	Director	$215,218	$804	$216,022
YAN XIONG	INVESTIGATOR	40.00	Highest	$213,788	$0	$213,788
JOHN MUNZ	VP, HUMAN RESOURCES	40.00	Key Emp	$200,731	$1,113	$201,844
DR HARRY ROSSITER	BOARD MEMBER/INVESTIGATOR	40.00	Director	$172,475	$644	$173,119
MICHAEL JONES	SVP & CFO	40.00	Officer	$106,504	$9,255	$115,759
DR ERIC DAAR	BOARD MEMBER/INVESTIGATOR/VICE CHAIR	40.00	Officer Director	$108,109	$0	$108,109
DR LYNNE SMITH	SECRETARY/BOARD MEMBER/INVESTIGATOR	40.00	Officer Director	$88,249	$0	$88,249
DR DELPHINE LEE	BOARD MEMBER/INVESTIGATOR	40.00	Director	$19,756	$0	$19,756
DR MITCHEL SAYARE	BOARD CHAIR, CHAIR - EXECUTIVE	2.00	Officer Director	$0	$0	$0
MR PAUL KUC	CHAIR - FINANCE, TREASURER	2.00	Officer Director	$0	$0	$0
MR SAM GLICK	CHAIR - ADVANCEMENT, VICE CHAIR	2.00	Director	$0	$0	$0
MR STEVEN NISSEN	CHAIR - GOVERNANCE & NOMINATIONS	2.00	Director	$0	$0	$0
MS LAURA SURVANT	CHAIR - EXECUTIVE COMPENSATION	2.00	Director	$0	$0	$0
MR JOSEPH BERENATO	CHAIR - AUDIT/RISK MANAGEMENT	2.00	Director	$0	$0	$0
MR H FREDERICK CHRISTIE	BOARD MEMBER	2.00	Director	$0	$0	$0
DR CHRISTIAN DEVIRGILIO	BOARD MEMBER	2.00	Director	$0	$0	$0
MR CARL DICKERSON	BOARD MEMBER	2.00	Director	$0	$0	$0
DR DAVID HEBER	BOARD MEMBER	2.00	Director	$0	$0	$0
MR NATE KIRTMAN	BOARD MEMBER	2.00	Director	$0	$0	$0
MR TOM ANASTASSIOU	BOARD MEMBER	2.00	Director	$0	$0	$0
DR CHRISTOPHER LEE	BOARD MEMBER	2.00	Director	$0	$0	$0
MR RICHARD LUNDQUIST	BOARD MEMBER	2.00	Director	$0	$0	$0
DR ANISH MAHAJAN	BOARD MEMBER	2.00	Director	$0	$0	$0
MR DANIEL ROSENFELD	BOARD MEMBER	2.00	Director	$0	$0	$0
DR SAMUEL TARICA	BOARD MEMBER	2.00	Director	$0	$0	$0
DR JOSEPH THOMAS	BOARD MEMBER/INVESTIGATOR	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$91,625,062	$99,189,062	$169,678,000	$-7,564,000
2022	$85,153,761	$91,968,761	$185,346,000	$-6,815,000
2021	$88,849,610	$90,527,887	$198,389,340	$-1,678,277
2020	$93,590,688	$88,086,650	$196,227,391	$5,504,038
2018	$88,251,402	$82,190,809	$124,192,277	$6,060,593

LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER